Tan Ke, Di Yu-fen, Cheng De-hua, Xu Fang, Lu Guang-xiu, Tan Yue-qiu
Institute of Reproduction and Stem Cell Engineering, Central South University, Changsha, Hunan, 410008 PR China.
Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2010 Aug;27(4):387-92. doi: 10.3760/cma.j.issn.1003-9406.2010.04.006.
To establish a single-cell whole genome amplification (WGA) technique, in combination with comparative genomic hybridization (CGH), for analyzing chromosomal copy number changes, and to explore its clinical application in preimplantation genetic diagnosis (PGD).
Twelve single-cell samples with known karyotypes, including 5 chorionic villus samples, 4 human embryonic stem cell (hESC) samples and 3 peripheral lymphocyte samples, and 4 single blastomere samples carrying chromosomal abnormalities detected by PGD, were collected for whole genome amplification by combining primer extension preamplification (PEP) with degenerate oligonucleotide primed-PCR (DOP-PCR) amplification. The amplified products labeled by red fluorescence were mixed with control DNA labeled by green fluorescence, and then the mixture was analyzed by CGH. As a comparison, 10 single cell samples were amplified by DOP-PCR only and then CGH analysis was performed.
The amplification using PEP-DOP-PCR was more stable than traditional DOP-PCR. The products of PEP-DOP-PCR range from 100 bp to 1000 bp, with the mean size being about 400 bp. The CGH results were consistent with analyses by other methods. However, only 6 out of 10 single cell samples were successfully amplified by DOP-PCR, and CGH analysis showed a high background and 2 samples showed inconsistent results from other methods.
PEP-DOP-PCR can effectively amplify the whole genome DNA of single cell. Combined with CGH, this WGA method can successfully detect single-cell chromosomal copy number changes, while DOP-PCR was easy to fail to amplify and amplify inhomogeneously, and CGH analysis using this PCR product usually showed high background. These results suggest that PEP-DOP-CGH is a promising method for preimplantation genetic diagnosis.
建立一种单细胞全基因组扩增(WGA)技术,并结合比较基因组杂交(CGH)分析染色体拷贝数变化,探讨其在植入前遗传学诊断(PGD)中的临床应用。
收集12个已知核型的单细胞样本,包括5个绒毛膜绒毛样本、4个人类胚胎干细胞(hESC)样本和3个外周血淋巴细胞样本,以及4个经PGD检测携带染色体异常的单细胞卵裂球样本,采用引物延伸预扩增(PEP)与简并寡核苷酸引物PCR(DOP-PCR)扩增相结合的方法进行全基因组扩增。将用红色荧光标记的扩增产物与用绿色荧光标记的对照DNA混合,然后通过CGH进行分析。作为对照,10个单细胞样本仅用DOP-PCR进行扩增,然后进行CGH分析。
PEP-DOP-PCR扩增比传统的DOP-PCR更稳定。PEP-DOP-PCR产物大小范围为100 bp至1000 bp,平均大小约为400 bp。CGH结果与其他方法的分析结果一致。然而,10个单细胞样本中只有6个通过DOP-PCR成功扩增,CGH分析显示背景较高,2个样本的结果与其他方法不一致。
PEP-DOP-PCR能有效扩增单细胞的全基因组DNA。结合CGH,这种WGA方法能成功检测单细胞染色体拷贝数变化,而DOP-PCR容易扩增失败和扩增不均一,用该PCR产物进行CGH分析通常显示背景较高。这些结果表明PEP-DOP-CGH是一种有前景的植入前遗传学诊断方法。